Author:
Townsley C A,Major P,Siu L L,Dancey J,Chen E,Pond G R,Nicklee T,Ho J,Hedley D,Tsao M,Moore M J,Oza A M
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Carpenter G, Cohen S (1990) Epidermal growth factor. J Biol Chem 265: 7709–7712
2. Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan refractory metastatic colorectal cancer. N Engl J Med 351: 337–345
3. Fisher GA, Kuo T, Cho CD, Halsey J, Jambalos CN, Schwartz EJ, Robert RV, Advani RH, Wakelee HA, Sikic BI (2004) A phase II study of gefitinib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer. Proc Am Soc Clin Oncol 22: 14S (abstr. 187)
4. Giacchetti S, Perpoint B, Zidani R, Le Bail N, Faggiuolo R, Focan C, Chollet P, Llory JF, Letourneau Y, Coudert B, Bertheaut-Cvitkovic F, Larregain-Fournier D, Le Rol A, Walter S, Adam R, Misset JL, Levi F (2000) Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil–leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18: 136–147
5. Gordon AN, Finkler N, Edwards RP, Garcia AA, Crozier M, Irwin DH, Barrett E (2005) Phase 2 evaluation of OSI-774, a potent oral antagonist of the EGFR-TK in patients with advanced ovarian cancer. Int J Gynecol Cancer 15: 785–792
Cited by
119 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献